OptMyCare Raises $3M in Series A Funding to Enhance AI-Driven Healthcare and Risk Management
OptMyCare offers a scalable, secure, and cloud-based SaaS product that merges precision analytics with actionable risk stratification solutions.
Company Name: OptMyCare
Location: Dallas, TX
Sector: Healthcare Technology, Artificial Intelligence
Funding Details:
OptMyCare, a provider of a clinically engineered AI healthcare and risk management platform, has secured $3 million in Series A funding, bringing the total funding to $4.5 million. The investment round was led by LiveOak Ventures.
Purpose of the Investment:
The funds will be utilized to accelerate customer acquisition, refine the company’s technology, onboard key management personnel, and strengthen the team with experienced healthcare and technology leaders.
Founders:
Founded in 2019 by Dr. Antony E. Pfaffle, MD, and Dr. Saravanan Balamuthusamy, MD, MPH, FASN, FASDIN, OptMyCare is at the forefront of integrating AI into healthcare management.
Product Overview:
OptMyCare offers a scalable, secure, and cloud-based SaaS product that merges precision analytics with actionable risk stratification solutions. The platform is designed for managing multiple chronic conditions and delivers real-time, data-driven recommendations. It uses clinically-engineered algorithms to process data from 55 chronic clinical diagnoses, their associated procedures, and claims costs, facilitating rapid and accurate risk identification.
Vision and Future Plans:
With this funding, OptMyCare is poised to expand its market presence and continue innovating in the intersection of AI and healthcare. The company aims to transform how chronic conditions are managed, making healthcare more predictive and preventive.